Monica Montone Department of Molecular Biotechnology and Health Sciences, University of Turin - Molecular Biotechnology Center, Italy
1 protocol

Michela Spadaro Neurobiology Unit , Neuroscience Institute Cavalieri Ottolenghi (NICO), Italy
1 protocol

Federica Cavallo
  • Department of Molecular Biotechnology and Health Sciences, University of Turin - Molecular Biotechnology Center, Italy
  • 1 Author merit

Education

Ph. D. in Immunology, University of Torino, Italy, 1994

Current position

Associate professor of Immunology, University of Torino, Italy (2006-present)

Publications (since 2010)

h index: 33, ISI Web of Science Thomson Reuters; the complete list of scientific publications is available at: http://www.researcherid.com/rid/C-5666-2011

  1. Cavallo, F., Aurisicchio, L., Mancini, R. and Ciliberto, G. (2014). Xenogene vaccination in the therapy of cancer. Expert Opin Biol Ther: 1-16.
  2. Riccardo, F., Iussich, S., Maniscalco, L., Lorda-Mayayo, S., La Rosa, G., Arigoni, M., De Maria, R., Gattino, F., Lanzardo, S. and Lardone, E. (2014). CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA. Clinical Cancer Research: clincanres. 3042.2013.
  3. Masuelli, L., Fantini, M., Benvenuto, M., Sacchetti, P., Giganti, M. G., Tresoldi, I., Lido, P., Lista, F., Cavallo, F., Nanni, P., Schlom, J., Modesti, A. and Bei, R. (2014). Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells. J Transl Med 12: 122.
  4. Riccardo, F., Arigoni, M., Buson, G., Zago, E., Iezzi, M., Longo, D. L., Carrara, M., Fiore, A., Nuzzo, S. and Bicciato, S. (2014). Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. BMC Genomics 15(3): 1-11.
  5. Macagno, M., Bandini, S., Stramucci, L., Quaglino, E., Conti, L., Balmas, E., Smyth, M. J., Lollini, P. L., Musiani, P., Forni, G., Iezzi, M. and Cavallo, F. (2014). Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice. J Immunol 192(11): 5434-5441.
  6. Occhipinti, S., Sponton, L., Rolla, S., Caorsi, C., Novarino, A., Donadio, M., Bustreo, S., Satolli, M. A., Pecchioni, C., Marchini, C., Amici, A., Cavallo, F., Cappello, P., Pierobon, D., Novelli, F. and Giovarelli, M. (2014). Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients. Clin Cancer Res 20(11): 2910-2921.
  7. Bolli, E., Conti, L., Riccardo, F., Marchini, C., Amici, A., Cavallo, F. and Quaglino, E. (2014). Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9-11, 2013. Cancer Immunol Immunother 63(5): 529-533.
  8. De Giovanni, C., Nicoletti, G., Quaglino, E., Landuzzi, L., Palladini, A., Ianzano, M. L., Dall'Ora, M., Grosso, V., Ranieri, D., Laranga, R., Croci, S., Amici, A., Penichet, M. L., Iezzi, M., Cavallo, F., Nanni, P. and Lollini, P. L. (2014). Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2. Breast Cancer Res 16(1): R10.
  9. Dentelli, P., Cavallo, F. and Brizzi, M. F. (2014). Membrane-bound KIT ligand-targeting DNA vaccination inhibits mammary tumor growth. Oncoimmunology 3(1): e27259.
  10. Ross, J. A., Spadaro, M., Rosado, D. C., Cavallo, F., Kirken, R. A. and Pericle, F. (2014). Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignancies. Leukemia 28(4): 941-944.
  11. Olgasi, C., Dentelli, P., Rosso, A., Iavello, A., Togliatto, G., Toto, V., Liberatore, M., Barutello, G., Musiani, P., Cavallo, F. and Brizzi, M. F. (2014). DNA vaccination against membrane-bound Kit ligand: a new approach to inhibiting tumour growth and angiogenesis. Eur J Cancer 50(1): 234-246.
  12. Spadaro, M., Montone, M., Arigoni, M., Cantarella, D., Forni, G., Pericle, F., Pascolo, S., Calogero, R. A. and Cavallo, F. (2014). Recombinant human lactoferrin induces human and mouse dendritic cell maturation via Toll-like receptors 2 and 4. FASEB J 28(1): 416-429.
  13. Lollini, P. L., Cavallo, F., De Giovanni, C. and Nanni, P. (2013). Preclinical vaccines against mammary carcinoma. Expert Rev Vaccines 12(12): 1449-1463.
  14. Bandini, S., Curcio, C., Macagno, M., Quaglino, E., Arigoni, M., Lanzardo, S., Hysi, A., Barutello, G., Consolino, L., Longo, D. L., Musiani, P., Forni, G., Iezzi, M. and Cavallo, F. (2013). Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice. Oncoimmunology 2(9): e26137.
  15. Conti, L., Lanzardo, S., Arigoni, M., Antonazzo, R., Radaelli, E., Cantarella, D., Calogero, R. A. and Cavallo, F. (2013). The noninflammatory role of high mobility group box 1/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells. FASEB J 27(12): 4731-4744.
  16. Cordero, F., Beccuti, M., Fornari, C., Lanzardo, S., Conti, L., Cavallo, F., Balbo, G. and Calogero, R. (2013). Multi-level model for the investigation of oncoantigen-driven vaccination effect. BMC Bioinformatics 14 Suppl 6: S11.
  17. Carrara, M., Beccuti, M., Cavallo, F., Donatelli, S., Lazzarato, F., Cordero, F. and Calogero, R. A. (2013). State of art fusion-finder algorithms are suitable to detect transcription-induced chimeras in normal tissues? BMC Bioinformatics 14 Suppl 7: S2.
  18. Marchini, C., Kalogris, C., Garulli, C., Pietrella, L., Gabrielli, F., Curcio, C., Quaglino, E., Cavallo, F. and Amici, A. (2013). Tailoring DNA Vaccines: Designing Strategies Against HER2-Positive Cancers. Front Oncol 3: 122.
  19. Arigoni, M., Barutello, G., Riccardo, F., Ercole, E., Cantarella, D., Orso, F., Conti, L., Lanzardo, S., Taverna, D., Merighi, I., Calogero, R. A., Cavallo, F. and Quaglino, E. (2013). miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2. Am J Pathol 182(6): 2058-2070.
  20. Carrara, M., Beccuti, M., Lazzarato, F., Cavallo, F., Cordero, F., Donatelli, S. and Calogero, R. A. (2013). State-of-the-art fusion-finder algorithms sensitivity and specificity. Biomed Res Int 2013: 340620.
  21. Conti, L., Lanzardo, S., Iezzi, M., Montone, M., Bolli, E., Brioschi, C., Maiocchi, A., Forni, G. and Cavallo, F. (2013). Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe binding alphav beta3 integrins. Contrast Media Mol Imaging 8(4): 350-360.
  22. Ronchi, G., Gambarotta, G., Di Scipio, F., Salamone, P., Sprio, A. E., Cavallo, F., Perroteau, I., Berta, G. N. and Geuna, S. (2013). ErbB2 receptor over-expression improves post-traumatic peripheral nerve regeneration in adult mice. PLoS One 8(2): e56282.
  23. Cappello, P., Rolla, S., Chiarle, R., Principe, M., Cavallo, F., Perconti, G., Feo, S., Giovarelli, M. and Novelli, F. (2013). Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer. Gastroenterology 144(5): 1098-1106.
  24. Conzo, G., Mauriello, C., Gambardella, C., Napolitano, S., Cavallo, F., Tartaglia, E. and Santini, L. (2013). Gallstone ileus: One-stage surgery in an elderly patient: One-stage surgery in gallstone ileus. Int J Surg Case Rep 4(3): 316-318.
  25. Iezzi, M., Calogero, R. A., Spadaro, M., Musiani, P., Forni, G. and Cavallo, F. (2012). BALB-neuT female mice as a flexible model of mammary cancer. In: Wang, X. K. (ed). Animal Models of Diseases: Translational Medicine Perspective for Drug Discovery and Development, Chapter 6. Bentham Science Publishers Ltd, 139-166.
  26. Arigoni, M., Barutello, G., Lanzardo, S., Longo, D., Aime, S., Curcio, C., Iezzi, M., Zheng, Y., Barkefors, I., Holmgren, L. and Cavallo, F. (2012). A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. Angiogenesis 15(2): 305-316.
  27. Burkhardt, U. E., Sloots, A., Jakobi, V., Wei, W. Z., Cavallo, F., Kloke, B. P. and Wels, W. S. (2012). IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells. Cancer Immunol Immunother 61(9): 1473-1484.
  28. Quaglino, E., Riccardo, F., Macagno, M., Bandini, S., Cojoca, R., Ercole, E., Amici, A. and Cavallo, F. (2011). Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans. Cancers (Basel) 3(3): 3225-3241.
  29. Iezzi, M., Quaglino, E., Cappello, P., Toto, V., Sabatini, F., Curcio, C., Garotta, G., Musiani, P. and Cavallo, F. (2011). HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. Int J Immunopathol Pharmacol 24(3): 621-630.
  30. Mayayo, S. L., Prestigio, S., Maniscalco, L., La Rosa, G., Arico, A., De Maria, R., Cavallo, F., Ferrone, S., Buracco, P. and Iussich, S. (2011). Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma. Vet J 190(2): e26-30.
  31. Riganti, C., Pinto, H., Bolli, E., Belisario, D. C., Calogero, R. A., Bosia, A. and Cavallo, F. (2011). Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer. Biochem Pharmacol 82(9): 1079-1089.
  32. Berta, G. N., Sprio, A. E., Iezzi, M., Spadaro, M., Cappia, S., Salamone, P., Di Scipio, F., Mognetti, B., Papotti, M., Musiani, P., Forni, G. and Cavallo, F. (2011). A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters. Cancer Prev Res (Phila) 4(7): 994-1001.
  33. Cavallo, F., De Giovanni, C., Nanni, P., Forni, G. and Lollini, P. L. (2011). 2011: the immune hallmarks of cancer. Cancer Immunol Immunother 60(3): 319-326.
  34. Noris, E., Poli, A., Cojoca, R., Ritta, M., Cavallo, F., Vaglio, S., Matic, S. and Landolfo, S. (2011). A human papillomavirus 8 E7 protein produced in plants is able to trigger the mouse immune system and delay the development of skin lesions. Arch Virol 156(4): 587-595.
  35. Lollini, P. L., Nicoletti, G., Landuzzi, L., Cavallo, F., Forni, G., De Giovanni, C. and Nanni, P. (2011). Vaccines and other immunological approaches for cancer immunoprevention. Curr Drug Targets 12(13): 1957-1973.
  36. Bolli, E., Quaglino, E., Arigoni, M., Lollini, P. L., Calogero, R., Forni, G. and Cavallo, F. (2011). Oncoantigens for an immune prevention of cancer. Am J Cancer Res 1(2): 255-264.
  37. Triulzi, C., Vertuani, S., Curcio, C., Antognoli, A., Seibt, J., Akusjarvi, G., Wei, W. Z., Cavallo, F. and Kiessling, R. (2010). Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors. Cancer Res 70(19): 7431-7441.
  38. Rolla, S., Ria, F., Occhipinti, S., Di Sante, G., Iezzi, M., Spadaro, M., Nicolo, C., Ambrosino, E., Merighi, I. F., Musiani, P., Forni, G. and Cavallo, F. (2010). Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy. J Immunol 184(11): 6124-6132.
  39. Porzia, A., Lanzardo, S., Citti, A., Cavallo, F., Forni, G., Santoni, A., Galandrini, R. and Paolini, R. (2010). Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies. J Immunol 184(8): 4170-4177.
  40. Quaglino, E., Mastini, C., Amici, A., Marchini, C., Iezzi, M., Lanzardo, S., De Giovanni, C., Montani, M., Lollini, P. L., Masucci, G., Forni, G. and Cavallo, F. (2010). A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. Cancer Res 70(7): 2604-2612.
  41. Barbieri, I., Pensa, S., Pannellini, T., Quaglino, E., Maritano, D., Demaria, M., Voster, A., Turkson, J., Cavallo, F., Watson, C. J., Provero, P., Musiani, P. and Poli, V. (2010). Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten. Cancer Res 70(6): 2558-2567.
  42. Barbieri, I., Quaglino, E., Maritano, D., Pannellini, T., Riera, L., Cavallo, F., Forni, G., Musiani, P., Chiarle, R. and Poli, V. (2010). Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. Mol Carcinog 49(2): 114-120.
  43. Coscia, M., Quaglino, E., Iezzi, M., Curcio, C., Pantaleoni, F., Riganti, C., Holen, I., Monkkonen, H., Boccadoro, M., Forni, G., Musiani, P., Bosia, A., Cavallo, F. and Massaia, M. (2010). Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. J Cell Mol Med 14(12): 2803-2815.
1 Protocol published
Generation and Maturation of Human Monocyte-derived DCs
Authors:  Michela Spadaro, Monica Montone and Federica Cavallo, date: 08/05/2014, view: 14875, Q&A: 0
Dendritic cells (DC) are antigen-presenting cells, which play a critical role in the regulation of the adaptive immune response. They act as a bridge between the innate and the adaptive immune systems. An approach to study their function and ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.